ArticleBMC health services research2019
Knowledge, provision of information and barriers to high quality medication abortion provision by pharmacists in Uttar Pradesh, India.
Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Medical abortion offered in pharmacy versus clinic-based settings.The Cochrane database of systematic reviews · 2021Pooled it
- Mystery Client Methodologies to Evaluate Abortion Care and Access: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
- Ensuring an enabling environment for abortion self-care: individuals' experiences with self-managed abortion in India.BMJ global health · 2026Article
- Exploring the availability and accessibility of medication abortion pills without a prescription: a mystery client study of pharmacies in Mumbai, India.BMC public health · 2026Article
- "I Was Confident From the Bottom of My Heart That I Will be Fine With These Medicines": Qualitative Analysis of Decision-Making Around Self-Managed Abortion Trajectories in India.Studies in family planning · 2025Article
- Supporting self-managed abortion care in "practice not premise": a qualitative study of provider perspectives, roles, and information pathways to care in India.Sexual and reproductive health matters · 2025Article
- Self-Managed Medication Abortion: History, Evidence, Models of Care, and Policy Considerations.American journal of public health · 2025Article
- Quality of Information on Medication Abortion in Private Pharmacies: Results from a Mystery Client Study in Kinshasa, Democratic Republic of Congo.Healthcare (Basel, Switzerland) · 2025Article
- Medical abortion drug dispensing practices among private pharmacy workers in Nepal: A mystery client study.PloS one · 2022Article
- Article
- A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.Sexual and reproductive health matters · 2021Article
- Differential treatment in the provision of medication abortion at pharmacies in Uttar Pradesh, India.AJOG global reports · 2021Article
- Running an obstacle-course: a qualitative study of women's experiences with abortion-seeking in Tamil Nadu, India.Sexual and reproductive health matters · 2021Article
- Medical abortion kit dispensing practices of community pharmacies in Pokhara Metropolitan, Nepal.PloS one · 2021Article
- Understanding abortion-related complications in health facilities: results from WHO multicountry survey on abortion (MCS-A) across 11 sub-Saharan African countries.BMJ global health · 2021Article
- Incidence of treatment for postabortion complications in India, 2015.BMJ global health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of medication abortion is increasing rapidly in India, the majority of which is purchased through pharmacies. More information is needed about the quality of services provided by pharmacist about medication abortion, especially barriers to providing high quality information. The goal of this study was to explore the quality of pharmacist medication abortion provision using mixed methods to inform the developed of an intervention for this population.
methodsData was collected via convenience sampling using three methods: a quantitative survey of pharmacists (N = 283), mystery clients (N = 111), and in-depth qualitative interviews with pharmacist (N = 11). Quality indictors from the quantitative data from surveys and mystery clients were compared. Qualitative interviews were used to elucidate reasons behind findings from the quantitative survey.
resultsQuality of information provided to client purchasing medication abortion was low, especially related to timing and dosing of misoprostol (18% of pharmacists knew correct timing) and side effects (31% not telling any information on side effects). Mystery clients reported lower quality (less correct information) than pharmacists reported about their own behaviors. Qualitative interviews suggested that many barriers exist for pharmacists, including perceptions about what information clients can understand and desire, and also lack of comfort giving certain information to certain types of clients (young women).
conclusionsIt is essential to improve the quality of information given to client purchasing medication abortion from pharmacists. Our findings highlight specific gaps in knowledge and reasons for poor quality information. Differences in guidelines available at that time from the Indian Government, World Health Organization, and the medication abortion boxes may lead to confusion amongst pharmacists and potentially clients. Interventions need to improve both knowledge about medication abortion and also biases in the provision of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.